BioTrinity is an established, must-attend London conference, that catalyses growth and supports in-person engagement across the life sciences industry.
The event is attended by an audience of early stage and emerging life sciences R&D companies, investors, big pharma, and other valued partners throughout the life sciences ecosystem. The conference features a focused, relevant, and stimulating programme, led by great speakers, who bring their knowledge, expertise, and vision to the fore in exciting, high-quality sessions.
Interacting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased.
A dedicated 'Scientific Track', featuring a focus on eight core therapy areas; Oncology, Neuroscience, Microbiome, Inflammatory Diseases, Rare Diseases, Infectious Diseases, Medtech and Cell & Gene Therapy. Each dedicated session will include an expert update from a key opinion leader, followed by up to 5 showcase presentations from some of the most innovative and interesting R&D companies.
A second 'life sciences business' focused presentation track, that will feature discussions and keynotes addressing topics from finance and investment, regulatory, government strategy and tax.
Pre-scheduled live & in-person private partnering meetings during the two-day physical conference as well as a bonus third day of virtual only partnering.
A sponsors exhibition area and plenty of 'all-delegate' networking opportunities throughout both in-person day, which are so valuable to share knowledge and unlock future collaboration and new business opportunities.
Option for registered delegates to revisit recorded presentations in the days following the conference.
BioTrinity Investor Drinks Reception and BioTrinity Networking Party events open to conference delegates.